Oct 28 (Reuters) - Telesta Therapeutics Inc TST.TO :
* Press release - Telesta Therapeutics and Ipsen announce exclusive license
agreement for MCNA(1) for the treatment of non-muscle invasive bladder cancer
in major ex-United States territories
* Under financial terms of the agreement, Telesta is eligible to receive up to
US$137 million in upfront and milestone payments
* Is eligible to receive meaningful tiered double-digit royalties on net sales
of MCNA in the licensed territories
* Says deal is for all countries with exception of United States,Canada, South
Africa, Mexico, South Korea and Japan
* Source text for Eikon ID:nPn6RQHwd
* Further company coverage TST.TO